RenovoRx, Inc. (RNXT) Financial Statements (2024 and earlier)

Company Profile

Business Address 333 W. SANTA CLARA STREET, SUITE 900
SAN JOSE, CA 95110
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:6,400,00015,192,000
Cash and cash equivalents4,391,00015,192,000
Short-term investments 2,049,000 
Other undisclosed cash, cash equivalents, and short-term investments (40,000) 
Deferred costs  
Other undisclosed current assets 865,0001,089,000
Total current assets:7,265,00016,281,000
Noncurrent Assets
Property, plant and equipment  6,000
Total noncurrent assets:  6,000
Other undisclosed assets  
TOTAL ASSETS:7,265,00016,287,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,102,000938,000
Accounts payable534,000525,000
Accrued liabilities568,000413,000
Total current liabilities:1,102,000938,000
Noncurrent Liabilities
Other undisclosed noncurrent liabilities  
Total noncurrent liabilities:  
Total liabilities:1,102,000938,000
Equity
Equity, attributable to parent6,163,00015,349,000
Common stock1,0001,000
Additional paid in capital37,318,00036,632,000
Accumulated other comprehensive income 17,000 
Accumulated deficit(31,173,000)(21,284,000)
Total equity:6,163,00015,349,000
TOTAL LIABILITIES AND EQUITY:7,265,00016,287,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
Operating expenses(9,950,000)(5,671,000)
Operating loss:(9,950,000)(5,671,000)
Nonoperating income (expense)61,000(653,000)
Other nonoperating income 4,000119,000
Loss from continuing operations:(9,889,000)(6,324,000)
Loss before gain (loss) on sale of properties:(6,324,000)
Net loss available to common stockholders, diluted:(9,889,000)(6,324,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
Net loss:(9,889,000)(6,324,000)
Other comprehensive income (loss)17,000 
Other undisclosed comprehensive income  
Comprehensive loss:(9,872,000)(6,324,000)
Other undisclosed comprehensive loss, net of tax, attributable to parent  
Comprehensive loss, net of tax, attributable to parent:(9,872,000)(6,324,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: